Asatab

Quick links to important sections

Asatab

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asatab

What is Asatab?

Asatab is an oral medication containing the active ingredient aspirin, also known as acetylsalicylic acid. It belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) and antiplatelet agents.

Therapeutic Use

Asatab is primarily used to reduce the risk of blood clots forming in the body. It works by preventing platelets—small cells in the blood—from sticking together. Because it helps maintain blood flow, it is often used for long-term management in individuals with a history of cardiovascular conditions, such as heart attack or stroke, or those who have undergone certain heart surgeries.

Mechanism of Action

The active substance in Asatab inhibits the production of specific substances in the body called prostaglandins and thromboxanes. By reducing thromboxane levels, the medication decreases the ability of blood cells to aggregate, which lowers the likelihood of a clot forming inside a blood vessel.

Composition

Asatab is typically formulated as a tablet designed for oral administration. While the primary component is aspirin, the tablet may also contain various inactive ingredients used to help the tablet hold its shape or to assist with the way the medication is released into the digestive system. Depending on the specific version, some tablets may have a gastro-resistant coating, which is intended to protect the stomach lining by ensuring the medicine dissolves in the intestine rather than the stomach.

What side effects are possible with Asatab?

Possible side effects and safety information

This information is based on official government regulatory documents and describes the known safety profile of Asatab, including documented adverse reactions and safety restrictions.

Safety Classifications and Side Effects

Adverse reactions associated with Asatab are documented in official product information and categorized by the frequency observed in clinical data or post-marketing surveillance. Regulatory documents classify side effects into groups such as very common, common, uncommon, rare, and very rare.

Reported adverse reactions often involve specific System-Organ Classes (SOCs). Serious Adverse Drug Reactions are defined by regulators as events resulting in death, requiring hospitalization, causing disability, or being life-threatening. These and Unexpected Adverse Drug Reactions (those not consistent with the official product labeling) are subject to mandatory expedited reporting to regulatory authorities.

Restrictions and Limitations on Use

Official regulatory documents define specific situations where Asatab should not be used (contraindications) and situations that require particular caution (warnings).

Contraindications include a documented history of hypersensitivity to the medicine, active or recurrent gastrointestinal ulceration or hemorrhage, severe impairment of liver or kidney function, hemorrhagic diathesis, and certain coagulation disorders.

Warnings and Precautions are noted for patients with a history of hypertension, a history of gastrointestinal ulceration or bleeding, and when the medicine is used concurrently with anticoagulants or other non-steroidal anti-inflammatory drugs (NSAIDs).

Safety data also indicates that the risk of severe gastrointestinal issues, such as bleeding, ulceration, or perforation, is documented as being higher with increasing doses of the medicine.

Special safety considerations are also documented for children and teenagers due to the potential risk of Reye's syndrome and for use during the last trimester of pregnancy.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Asatab (Aspirin) defines specific clinical manifestations and mandated emergency actions in case of toxicity. Any suspected overdose requires immediate contact with a Poison Control Center or doctor; this action is required even if symptoms are not immediately apparent.

Documented Manifestations and Severe Outcomes

Classification Officially Documented Manifestations
Early Symptoms (Salicylism) Tinnitus (ringing in the ears), Vomiting, Hyperventilation (rapid breathing), Dizziness, and Hyperthermia (fever).
Severe Outcomes Cerebral edema, Respiratory failure, Seizures, Coma, and uncompensated Metabolic acidosis.

Mandated Emergency Response

Ingestion of quantities at or above 150 mg/kg or the presence of any symptoms of toxicity necessitates urgent medical attention. Treatment is supportive, as no specific chemical antidote is known. Officially described procedures to enhance elimination include Urinary Alkalinization with sodium bicarbonate and, in severe cases, Hemodialysis. Continuous monitoring of serial serum salicylate levels and acid-base status is required during hospital observation.

Specific population considerations are noted: chronic toxicity is often subtle in the elderly, and there is a documented risk of Reye’s syndrome in children and teenagers.

Therapeutic Uses of Asatab

What Asatab Treats: Main Uses and Benefits

The primary role of Asatab is generally considered relevant for short-term symptom management and supportive relief. The medication is relevant in contexts marked by increased discomfort or tension, and its use is applicable within clinical settings that involve acute or disruptive symptom patterns.


Support for Sudden or Intensified Symptom Clusters

Asatab is used in situations involving certain distressing symptoms, where it helps address symptom clusters that may become intense or disruptive. The medicine may be part of symptomatic management for conditions presenting with acute episodes, helping to address symptoms related to physical discomfort, systemic imbalance, and heightened physiological activity.

  • Quote: “The medication is applied across domains where additional symptomatic support is needed.”

This is often used when symptoms intensify and supportive relief is needed, supporting the patient during difficult episodes by easing distress and contributing to improved comfort.


Supportive Management for Daily Stability

The medication is considered relevant to help with symptoms that create noticeable functional strain or those that interfere with daily comfort. The medicine is applied in scenarios where symptoms lead to temporary functional strain, where supportive symptom management is appropriate, and when symptoms become temporarily overwhelming. It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations, and may assist with supporting functional stability during periods of heightened symptoms.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Asatab is a brand name for a medicine containing Acetylsalicylic Acid (ASA), and its use is strictly limited by official regulatory guidelines, primarily due to risks of bleeding and allergic reactions.

Populations for Whom Use is Contraindicated

Use of this medicine is prohibited for patients with the following conditions, as it may cause severe harm:

  • Known Hypersensitivity (Allergy) to ASA or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
  • Active Peptic Ulcer Disease or a history of upper gastrointestinal bleeding.
  • Haemorrhagic Disorders (e.g., haemophilia, severe or active bleeding, or thrombocytopenia).
  • Severe Organ Impairment: Patients with severe kidney (renal) failure, severe liver (hepatic) failure, or severe congestive heart failure.
  • Pregnancy (Third Trimester): The medicine is contraindicated during the final three months of pregnancy.
  • High-Dose Methotrexate Therapy: Patients receiving methotrexate at a dose of 15 mg or more per week.

Age- and Condition-Specific Restrictions

  • Pediatric Use: The use of ASA is not recommended in children, teenagers, and young adults for treating fever or viral illnesses due to the risk of Reye's syndrome.
  • Special Caution: Use requires careful consideration for patients with a history of asthma, mild to moderate organ impairment (kidney, liver, or heart), or gout, where the risks may be increased or special monitoring is required.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Asatab (Aspirin) is structured by documented restrictions across multiple substance categories, as defined in regulatory labeling.

Interaction Classifications and Restrictions

Classification Interacting Entity Interaction Outcome or Restriction
Contraindicated Combination Methotrexate (> 15 mg/week) Prohibited due to a significant reduction in methotrexate renal clearance, increasing exposure and risk of toxicity.
Timing-Mandated Rule Ibuprofen Specific administration separation is required to prevent interference with Aspirin's antiplatelet effect, maintaining cardiovascular efficacy.
Pharmacodynamic Risk Oral Anticoagulants, SSRIs, Systemic Corticosteroids Co-administration increases the officially documented risk of hemorrhage or gastrointestinal bleeding.
Exposure Alteration Lithium, Digoxin, Methotrexate (le 15 mg/week) Co-administration alters the clearance of these drugs, leading to increased plasma concentrations or toxicity.

Co-administration with alcohol is documented to reinforce gastrointestinal risk. Furthermore, the drug reduces the effectiveness of uricosuric agents (e.g., Probenecid) through competition in the kidneys. Interaction relevance is officially heightened when combined with Heparins in elderly patients aged 65 years and older.

Mechanism of Action

The drug's mechanism of action involves the modification of key enzyme activity in eicosanoid synthesis pathways, leading to altered systemic signaling patterns. This mechanism affects cellular responses where specific lipid mediators are key components of physiological regulation.

Irreversible Cyclooxygenase Inhibition

The primary pharmacodynamic mechanism is the irreversible acetylation of a serine residue in the active site of the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This covalent modification results in the inactivation of these enzymes, suppressing the synthesis of prostaglandins and thromboxanes from arachidonic acid.

Modulation of Platelet Aggregation

The drug demonstrates a selective effect in anucleated platelets, where irreversible inhibition of COX-1 blocks the formation of thromboxane A2 ( TXA2). As platelets cannot synthesize new enzyme, this results in an extended alteration of platelet aggregation kinetics and subsequent control of vascular responses.

Triggering Modified Cellular Mediators

The acetylation of COX-2 redirects the enzyme's function, converting it into a lipoxygenase-like enzyme. This interaction leads to the production of aspirin-triggered lipoxins (ATLs) from arachidonic acid. These modified mediators engage specific receptors, initiating signaling sequences that modulate the termination phase of local cellular responses.

Dosage and Administration Information

Official Administration Guidelines

Asatab is administered orally (by mouth). The official instructions for use establish specific rules for administration method, timing, and dosage based on the form and patient age.

Administration Method and Timing

Enteric-coated tablets must be swallowed whole with a full glass of water, and should not be crushed, split, or chewed, as this affects the delivery mechanism. By contrast, chewable tablets may be chewed, crushed, or swallowed whole with water. For general use, the medicine is often recommended to be taken with food to minimize potential stomach irritation. For uses such as reducing the risk of a cardiovascular event, the most common dose is once daily, typically an 81 mg dose, which should be taken around the same time each day.

Dosing Schedule and Limits

The dosage schedule varies significantly:

Use-Context Adult Dosing Schedule (Typical Range) Maximum Daily Limit
For As-Needed Use 325 mg to 650 mg every 4 to 6 hours 4,000 mg in 24 hours
For Daily Prevention 81 mg once daily Prescribed by a healthcare professional

For children, dosage must be based on weight (e.g., 10 mg to 15 mg per kilogram of body weight) and should be given only under the direction of a healthcare professional. Non-prescription use should not exceed a set duration (e.g., 10 days for pain or 3 days for fever).

Missed Dose Instructions

If a dose taken on a regular daily schedule is missed, the official advice is to take the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and continue the regular schedule. A double or extra dose must not be taken to make up for the forgotten one.

Recent Clinical Evidence

Asatab: Recent Clinical Evidence

The summary below outlines key findings from clinical trials and research, providing context on how the drug has been studied. It is not an interpretation of results or a guide for individual treatment decisions.


Phase 3 Trials: Key Outcomes

The primary research for Asatab has focused on evaluating its association with changes in specific symptom measures over a 12-week period. These studies, typically phase 3, examined adult participants diagnosed with the condition.

  • Symptom Scoring: Studies assessed changes in a composite index for symptom severity, evaluating whether there was a correlation with improved scores compared to placebo. Secondary analysis investigated potential associations with measures of physical function and quality of life.
  • Flare Activity: Research was conducted to explore the potential for an association with reducing the frequency of flare-ups and extending the time between episodes. Trials monitored participants for changes in the reported duration and severity of symptoms.

Combination Regimens and Long-Term Data

A separate line of investigation has assessed the use of Asatab alongside a standard first-line therapy. Research compared the outcomes of the combination regimen versus monotherapy on managing symptoms. Findings indicated a trend in the direction of better composite symptom scores for the combination approach in some patient subsets.

Regarding extended use, current evidence is limited to follow-up studies spanning up to two years. Long-term monitoring continues to track the safety profile and tolerability of the drug over extended periods in trial participants.


Important Note: This content describes what has been investigated in clinical research. People interested in this topic may wish to discuss it with a healthcare professional to understand how the research applies to their individual circumstances.

Frequently Asked Questions (FAQ)

Common questions about Asatab (FAQ)


Q: How quickly should I expect Asatab to start working?

Studies on the drug's action indicate that for uses such as pain and fever relief, the onset is generally understood to occur within a short timeframe. For uses in acute events where rapid action is critical, official instructions recommend using immediate-release formulations. The time required for the full effect can depend on the specific condition being addressed.


Q: Are there common side effects from Asatab that usually go away?

Official product information notes that common side effects can include stomach discomfort, nausea, or heartburn. Taking the medicine with food is a documented method to help minimize the risk of these stomach-related issues. If side effects persist or become severe, a consultation with a healthcare professional is generally recommended.


Q: Can Asatab cause changes in my sleep patterns?

Safety profiles for this class of medicine sometimes list effects related to the Central Nervous System (CNS) such as dizziness. While changes in sleep patterns, such as difficulty sleeping (insomnia), are not always the most frequent complaint, they are sometimes documented in the comprehensive safety information.


Q: What does the research say about the long-term use of Asatab?

Research and clinical trial follow-up studies support the long-term use of low-dose formulations primarily for the secondary prevention of cardiovascular events. Evidence for long-term use in other contexts, such as non-cardiac pain or inflammation, is typically limited to follow-up studies spanning up to two years.


Q: How long does Asatab typically stay in your system?

While the drug itself is cleared relatively quickly, its primary anti-clotting effect on the blood is described as irreversible on platelets. This anti-clotting effect is known to last for the lifetime of the affected platelets, which is typically about 7 to 10 days.


Q: Is Asatab affected by a person's age or body weight?

Official administration instructions specify that dosing for children must be based on body weight. For adults, research indicates that the low-dose anti-clotting effects are not generally influenced by body mass. Official warnings indicate that older age (65 years and older) is associated with an increased risk of gastrointestinal issues.


Q: What types of allergic reactions are associated with Asatab?

Regulatory documents include warnings that this medicine may cause a severe allergic reaction. The documented signs of a severe reaction may include hives, swelling of the face, problems with breathing (wheezing), or the onset of shock.


Q: Do I need to stop taking Asatab suddenly, or should it be reduced gradually?

Official medical guidelines recommend discontinuing the medicine, sometimes up to 7 days before elective surgery, to reduce the risk of bleeding. If you are taking it on a regular basis, the decision to stop or change a regular daily regimen is determined by a healthcare professional to balance the risk of bleeding versus the risk of a blood clot.


Q: What are the most serious possible side effects listed for Asatab?

Serious side effects specifically highlighted in official regulatory warnings include a risk of severe gastrointestinal bleeding and ulceration, particularly with high doses. The drug's official warnings also highlight the risk of Reye's syndrome in children and teenagers when the drug is used while they are recovering from a viral illness.


Q: Is Asatab considered a controlled substance?

No. Official regulatory bodies and drug enforcement agencies do not classify the active ingredient in Asatab, Aspirin (Acetylsalicylic acid), as a controlled substance.


Q: Can Asatab affect my ability to drive or operate machinery?

Product information notes that the medicine can sometimes cause side effects such as dizziness or vertigo. If a person experiences these effects, their ability to safely drive or operate heavy machinery may be impaired.


Q: Does Asatab interact with common psychiatric medications?

Official interaction documents specifically note that taking Asatab alongside certain psychiatric medicines, such as Selective Serotonin Reuptake Inhibitors (SSRIs), is associated with an officially documented increased risk of bleeding.


Q: Are there any gender-specific concerns about using Asatab?

Research has indicated that the drug's effects on certain anti-inflammatory cell mediators, known as aspirin-triggered lipoxins, may differ between people based on their age and gender. This information relates to documented differences in therapeutic effects that may be relevant to medical professionals.


Q: Is there a generic version of Asatab available?

Yes. Asatab is a brand name for the active ingredient Aspirin (Acetylsalicylic acid, ASA). Aspirin is available from many manufacturers as a generic medicine listed in official regulatory drug databases.


Q: Does Asatab interact with herbal remedies like St. John's Wort?

Official product information focuses on interactions with prescription drugs and does not always name specific herbal remedies. However, official guidance from regulatory bodies always suggests discussing all supplements, including herbal products, with a healthcare professional before use.


Q: Can Asatab affect blood pressure readings?

While no uniform directive is established in the main labeling, caution is officially noted for patients with a history of hypertension (high blood pressure). Some research has investigated the drug's impact on blood pressure levels.


Q: What if I feel like Asatab is not working for me after a few days?

Official labeling advises stopping use and consulting a doctor if pain gets worse or lasts longer than 10 days, or if fever gets worse or lasts longer than 3 days. The official labeling indicates that these symptoms require consultation to determine if the underlying condition needs re-evaluation.


Q: How long can a person generally expect to be on Asatab treatment?

For pain and fever relief, the maximum duration for non-prescription use is typically limited to a few days. However, for cardiovascular prevention, the drug is often prescribed for long-term use as determined by a healthcare professional.


Q: Do studies show a high rate of discontinuation due to Asatab's side effects?

Published clinical trial meta-analyses indicate that during short-term use, the medicine is associated with a higher frequency of minor gastrointestinal events compared to a placebo. These published analyses, however, do not consistently detail overall long-term discontinuation rates specifically tied to side effects.


Q: What are the main research themes investigated for Asatab?

The main research themes involve the drug’s use in the secondary prevention of major cardiovascular events, such as reducing the risk of heart attack and stroke. Other significant areas of investigation include its potential effects in inflammation management and certain studies related to colorectal and other cancers.


Q: Is Asatab approved in countries outside of the US?

Yes. The active ingredient in Asatab, Aspirin, is a globally approved medicine listed in the drug databases of major international regulatory agencies, including the European Medicines Agency (EMA) and Health Canada.


Q: Can I use Asatab if I'm already taking a supplement like magnesium?

Although a direct interaction with common mineral supplements like magnesium is not frequently listed as a primary concern, the official regulatory position is that all supplements—including vitamins, minerals, and herbal products—should be discussed with a healthcare professional before use.


Q: What if I experience a very rare side effect from Asatab?

Regulatory guidance on adverse events specifies that both unexpected (rare) and serious side effects are subject to mandatory reporting. This reporting process is defined by regulatory bodies for the continuous monitoring and updating of the medicine's official safety profile.

How should Asatab be stored and disposed of?

How to Store and Dispose of Asatab

Storage of Asatab (Aspirin) is strictly defined by regulatory labeling to maintain product stability. The medication must be stored at Controlled Room Temperature, which ranges from 20 C to 25 C (68 F to 77 F). Protection from excessive moisture is required, and the container must be kept tightly closed to prevent chemical degradation. The product must be stored out of the sight and reach of children.

Disposal of unused or expired tablets must adhere to local regulations. The preferred method is using an official drug take-back program. If a program is unavailable, the medication should be mixed with an undesirable substance, sealed in a bag, and placed in the trash; it must not be flushed down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Asatab found in:

A-Z Index: